Samsung Biologics Q2 Operating Profit Hits ₩586.4 Billion (approximately $397.2 Million), Up 23% YoY — BigGo Finance
Samsung Biologics (207940) posted second-quarter consolidated revenue of ₩1.32 trillion (approximately $894.7 million) and operating profit of ₩586.4…